PL1694271T3 - Glikozylacyjny mutant FSH - Google Patents

Glikozylacyjny mutant FSH

Info

Publication number
PL1694271T3
PL1694271T3 PL04783331T PL04783331T PL1694271T3 PL 1694271 T3 PL1694271 T3 PL 1694271T3 PL 04783331 T PL04783331 T PL 04783331T PL 04783331 T PL04783331 T PL 04783331T PL 1694271 T3 PL1694271 T3 PL 1694271T3
Authority
PL
Poland
Prior art keywords
fsh
glycosylation mutant
mutant
fsh glycosylation
lifes
Prior art date
Application number
PL04783331T
Other languages
English (en)
Inventor
Louise M Garone
Stephen J Arkinstall
William H Brondyk
Robert K Campbell
Xuliang Jiang
Sean D Mckenna
Mark Tepper
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of PL1694271T3 publication Critical patent/PL1694271T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/59Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Reproductive Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL04783331T 2003-09-02 2004-09-02 Glikozylacyjny mutant FSH PL1694271T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49980203P 2003-09-02 2003-09-02
PCT/US2004/029042 WO2005020934A2 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant
EP04783331A EP1694271B1 (en) 2003-09-02 2004-09-02 Fsh glycosylation mutant

Publications (1)

Publication Number Publication Date
PL1694271T3 true PL1694271T3 (pl) 2011-11-30

Family

ID=34272871

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04783331T PL1694271T3 (pl) 2003-09-02 2004-09-02 Glikozylacyjny mutant FSH

Country Status (23)

Country Link
US (1) US7700112B2 (pl)
EP (1) EP1694271B1 (pl)
JP (1) JP4653090B2 (pl)
KR (1) KR101099809B1 (pl)
CN (1) CN1984926B (pl)
AT (1) ATE511829T1 (pl)
AU (1) AU2004268683B2 (pl)
BR (1) BRPI0413206A (pl)
CA (1) CA2535522A1 (pl)
CY (1) CY1112439T1 (pl)
DK (1) DK1694271T3 (pl)
EA (1) EA012175B1 (pl)
ES (1) ES2367784T3 (pl)
HR (1) HRP20110430T1 (pl)
IL (1) IL174037A0 (pl)
MX (1) MXPA06002119A (pl)
NO (1) NO20061446L (pl)
PL (1) PL1694271T3 (pl)
PT (1) PT1694271E (pl)
SI (1) SI1694271T1 (pl)
UA (1) UA88879C2 (pl)
WO (1) WO2005020934A2 (pl)
ZA (1) ZA200601803B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG155183A1 (en) 2005-08-26 2009-09-30 Ares Trading Sa Process for the preparation of glycosylated interferon beta
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
WO2008010840A2 (en) * 2005-12-22 2008-01-24 Laboratoires Serono S.A. Fsh mutants
DK1981908T3 (da) * 2006-01-17 2010-12-13 Merck Serono Sa Ny FSH-glykosyleringsvariant D3N
EP2479571A3 (en) * 2007-03-26 2012-09-26 Novartis AG Predictive renal safety biomarkers and biomarker signatures to monitor kidney function
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
CN108676096B (zh) * 2018-05-22 2022-03-29 北京伟杰信生物科技有限公司 重组猪fsh-ctp融合蛋白及其制备方法与应用
CA3160345A1 (en) * 2019-11-06 2021-05-14 The Regents Of The University Of Colorado, A Body Corporate Modified follicle-stimulating hormone and methods of using the same
CN114213523B (zh) * 2021-11-15 2024-07-09 广州源博医药科技有限公司 一种用于重组蛋白的高糖基化修饰序列及其重组猪促卵泡激素和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923805A (en) 1983-11-02 1990-05-08 Integrated Genetics, Inc. Fsh
US5639639A (en) 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US4840896A (en) 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
US5156957A (en) 1983-11-02 1992-10-20 Genzyme Corporation Follicle stimulating hormone
US4845077A (en) 1984-04-03 1989-07-04 Serono Laboratories, Inc. Method of inducing ovulation
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
JP3045539B2 (ja) 1989-02-21 2000-05-29 ワシントン ユニバーシティ 改変型生殖ホルモン
US5338835A (en) 1989-02-21 1994-08-16 Washington University CTP-extended form of FSH
US5508261A (en) 1991-06-18 1996-04-16 University Of Medicine & Dentistry Of New Jersey Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same
US6407205B1 (en) 1997-06-04 2002-06-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College FSH-releasing peptides
EP0994718B1 (en) * 1997-06-20 2005-08-17 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
PT1102763E (pt) 1998-08-07 2005-01-31 Applied Research Systems Mimeticos fsh para o tratamento da infertilidade
CZ302835B6 (cs) 2000-01-27 2011-11-30 Laboratoires Serono Sa Farmaceutický prostredek
US20020127652A1 (en) * 2000-02-11 2002-09-12 Schambye Hans Thalsgard Follicle stimulating hormones
WO2001058493A1 (en) * 2000-02-11 2001-08-16 Maxygen Aps Conjugates of follicle stimulating hormones
CA2469724A1 (en) 2001-10-22 2004-06-17 Applied Research Systems Ars Holding N.V. Mutant glycoproteins

Also Published As

Publication number Publication date
HRP20110430T1 (hr) 2011-07-31
NO20061446L (no) 2006-03-30
KR101099809B1 (ko) 2011-12-27
DK1694271T3 (da) 2011-09-12
ZA200601803B (en) 2007-05-30
UA88879C2 (en) 2009-12-10
AU2004268683B2 (en) 2010-06-24
EA012175B1 (ru) 2009-08-28
EA200600526A1 (ru) 2007-04-27
BRPI0413206A (pt) 2006-10-03
PT1694271E (pt) 2011-07-07
IL174037A0 (en) 2006-08-01
SI1694271T1 (sl) 2011-08-31
WO2005020934A2 (en) 2005-03-10
JP4653090B2 (ja) 2011-03-16
CY1112439T1 (el) 2015-12-09
WO2005020934A3 (en) 2007-02-15
CA2535522A1 (en) 2005-03-10
ES2367784T3 (es) 2011-11-08
CN1984926B (zh) 2012-04-11
HK1101315A1 (en) 2007-10-12
EP1694271A2 (en) 2006-08-30
EP1694271B1 (en) 2011-06-08
AU2004268683A1 (en) 2005-03-10
CN1984926A (zh) 2007-06-20
MXPA06002119A (es) 2006-05-31
KR20070029620A (ko) 2007-03-14
US7700112B2 (en) 2010-04-20
AU2004268683A2 (en) 2005-03-10
ATE511829T1 (de) 2011-06-15
US20050100989A1 (en) 2005-05-12
JP2007508245A (ja) 2007-04-05

Similar Documents

Publication Publication Date Title
CY1112439T1 (el) Μεταλλαγμα fsh-γλυκοζυλιωσης
AU2003272536A8 (en) Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
GB0001309D0 (en) Valve arrangement
ZA981779B (en) The use of levobupivacaine in facial surgery
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
WO2007084441A3 (en) Novel fsh glycosylation variant d3n
AU2002352566A1 (en) Use of corrinoids in the treatment of skin diseases
WO2004050679A3 (en) Mutant glycoproteins
GB2404148B (en) Method of producing a manufactured article in silk indicated in the treatment of some skin diseases of the human body
UA93893C2 (en) Fsh mutants
USD467344S1 (en) Treatment couch
AU2003281257A8 (en) A novel use of rapamycin and structural analogues thereof
AU2002364889A8 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
GB0202410D0 (en) Treatment of IL deficiencies
CN2345194Y (zh) 一种扣叩器
USD519640S1 (en) Apparatus for fitness treatments of human body
ATE95995T1 (de) Ergonomisches kopfkissen, insbesondere zur verhuetung und/oder behandlung von nackenbeschwerden.
GR990100106A (el) Οργανο παθητικης κινησιοθεραπειας σε ορθια θεση για ατομα με αναπηρια στα κατω ακρα
TW519919U (en) Structure of health care chair capable of performing therapeutic ch'I-gong with biological spectrum
Velinova Qualities of the restorations of glass-ionomer cement of caries and non-caries lesions of the dental necks after a two-year observation period
SE9704451D0 (sv) New method and compositions for the treatment of autoimmune diseases
AU2002257610A1 (en) "acupuncture massage rod" and the use thereof in "electroporation therapy" ("elt")
MD1195F1 (en) Hemotherapy remedy
CA102676S (en) Cot
AU126541S (en) An attachment for a medical examination couch